URI(s)
- http://id.loc.gov/authorities/subjects/sh85005714
- http://id.loc.gov/authorities/sh85005714#concept
Variants
- Anticancer agents
- Antineoplastic drugs
- Antineoplastics
- Antitumor agents
- Antitumor drugs
- Cytotoxic drugs
- Inhibitors, Neoplasm
- Neoplasm inhibitors
Broader Terms
Narrower Terms
- Antimetabolites
- Antineoplastic antibiotics
- Arabinonucleosides
- Azacitidine
- Bestatin
- Bevacizumab
- Bisantrene hydrochloride
- Bromebric acid
- Camptothecin
- Cetuximab
- Cisplatin
- Curcumin
- Docetaxel
- Etoposide
- Fareston
- Fludarabine
- Fluorouracil
- Folinic acid
- Goserelin
- Imatinib
- Interferon
- Krebiozen
- Laetrile
- Lapatinib
- Lonidamine
- Methisazone
- Methotrexate
- Mitoxantrone hydrochloride
- Neovascularization inhibitors
- Octreotide acetate
- Oxaliplatin
- Paclitaxel
- Phorboxazoles
- Puromycin
- Quinacrine
- Rituximab
- Tamoxifen
- Trastuzumab
- Vinblastine
- Vincristine
- Vindesine
- Vinorelbine
Related Terms
Exact Matching Concepts from Other Schemes
Closely Matching Concepts from Other Schemes
Broader Concepts from Other Schemes
Antineoplastic agents--Administration 
- Antineoplastic agents--Analysis
- Antineoplastic agents--Design
- Antineoplastic agents--Mechanism of action
- Antineoplastic agents--Metabolism
- Antineoplastic agents--Physiological effect
- Antineoplastic agents--Research
- Antineoplastic agents--Safety measures
- Antineoplastic agents--Side effects
- Antineoplastic agents--Structure-activity relationships
- Antineoplastic agents--Synthesis
- Antineoplastic agents--Therapeutic use
- Antineoplastic agents--Toxicology
Sources
- found: Common usage in oncology.
LC Classification
- RC271.C5
- RS431.A64
Instance Of
Scheme Membership(s)
Collection Membership(s)
Change Notes
- 1986-02-11: new
- 1993-05-03: revised
Alternate Formats
